Innovation to improve drug delivery using polymer technology
Mithra has extensive expertise in the development of complex and innovative products using medical polymer technology. The company is leveraging this expertise to target improved, long-lasting delivery of trusted, established approaches to contraception, menopause and hormone-dependent cancers.
Mithra has developed the contraceptive vaginal ring Myring® and Tibelia®, a therapeutic solution composed of tibolone for menopause. It focuses now on the development of a biodegradable subcutaneous implant (Zoreline®) for hormone-dependant cancers.